| Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 |
|---|
|
Total Revenue
|
1,699,000
|
1,594,000
|
1,602,000
|
1,728,000
| | Cost of Revenue | 1,448,000 | 1,426,000 | 1,390,000 | 1,474,000 | | |
Gross Profit
|
251,000
|
168,000
|
212,000
|
254,000
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative | 185,000 | 193,000 | 178,000 | 296,000 |
|
Non Recurring | 8,000 | 7,000 | 5,000 | 8,000 |
|
Others | 12,000 | 13,000 | 12,000 | 12,000 |
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
46,000
|
(45,000)
|
17,000
|
(62,000)
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 6,000 | (7,000) | (10,000) | (7,000) |
|
Earnings Before Interest And Taxes | 61,000 | (46,000) | 77,000 | (121,000) |
|
Interest Expense | 29,000 | 32,000 | 96,000 | (33,000) |
|
Income Before Tax | 32,000 | (78,000) | (19,000) | (88,000) |
|
Income Tax Expense | 11,000 | (2,000) | (7,000) | (29,000) |
|
Minority Interest | (2,000) | (4,000) | 1,000 | (2,000) |
|
|
|
Net Income From Continuing Ops | 21,000 | (74,000) | (5,000) | (41,000) | |
|
Non-recurring Events |
|
Discontinued Operations | (53,000) |
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
(34,000)
|
(80,000)
|
(11,000)
|
(58,000)
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
(34,000)
|
(80,000)
|
(11,000)
|
(58,000)
|
|
0.14(1.51%) 2:36PM EDT - Nasdaq Real Time Price